Jennifer Jarrett - 04 Jun 2021 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role: Chief Operating Officer, Director
Signature: /s/ Carolyn Tang, Attorney-in-Fact
Issuer symbol: RCUS
Transactions as of: 04 Jun 2021
Net transactions value: -$26,006
Form type: 4
Filing time: 07 Jun 2021, 16:47:42 UTC
Next filing: 15 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCUS	Common Stock	Sale	$26,006	-1,044	-0.87%	$24.91	119,174	04 Jun 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	Includes 245 shares purchased on 5/28/2021 through the Company's Employee Stock Purchase Plan.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Includes 245 shares purchased on 5/28/2021 through the Company's Employee Stock Purchase Plan.